{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:38:05Z","timestamp":1781937485781,"version":"3.54.5"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:00:00Z","timestamp":1377734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11102-013-0511-3","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T11:37:19Z","timestamp":1377689839000},"page":"381-391","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of persistent and recurrent Cushing\u2019s disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Nina K.","family":"Sundaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza B.","family":"Geer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,29]]},"reference":[{"key":"511_CR1","first-page":"159","volume-title":"Pituitary adenomas: new trends in basic and clinical research","author":"B Ambrosi","year":"1991","unstructured":"Ambrosi B, Faglia G, the Multicenter Pituitary umor Study Group, Lombardia Region (1991) Epidemiology of pituitary tumors. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds) Pituitary adenomas: new trends in basic and clinical research. Excerpta Medica, Amsterdam, pp 159\u2013168"},{"issue":"4","key":"511_CR2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","volume":"40","author":"J Etxabe","year":"1994","unstructured":"Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40(4):479\u2013484","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"511_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","volume":"13","author":"CM Plotz","year":"1952","unstructured":"Plotz CM, Knowlton AI, Ragan C (1952) The natural history of Cushing\u2019s syndrome. Am J Med 13(5):597\u2013614","journal-title":"Am J Med"},{"issue":"7","key":"511_CR4","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stella GK, Swearingen B, Vance ML, Wass JA, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 93(7):2454\u20132462","journal-title":"J Clin Endocrinol Metab"},{"issue":"9258","key":"511_CR5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(00)04172-6","volume":"357","author":"M Boscaro","year":"2001","unstructured":"Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing\u2019s syndrome. Lancet 357(9258):783\u2013791","journal-title":"Lancet"},{"issue":"5","key":"511_CR6","first-page":"647","volume":"19","author":"J Newell-Price","year":"1998","unstructured":"Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states. Endocr Rev 19(5):647\u2013672","journal-title":"Endocr Rev"},{"issue":"10","key":"511_CR7","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jc.2006-0997","volume":"91","author":"JW Findling","year":"2006","unstructured":"Findling JW, Raff H (2006) Cushing\u2019s Syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91(10):3746\u20133753","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"511_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","volume":"141","author":"MN Starkman","year":"1981","unstructured":"Starkman MN, Schteingart DE (1981) Neuropsychiatric manifestations of patients with Cushing\u2019s syndrome. Relationship to cortisol and adrenocorticotropic hormone levels. Arch Intern Med 141(2):215\u2013219","journal-title":"Arch Intern Med"},{"issue":"4","key":"511_CR9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1995.tb02614.x","volume":"43","author":"LD Dorn","year":"1995","unstructured":"Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kling M, Gold PW, Chrousos GP (1995) Psychopathology in patients with endogenous Cushing\u2019s syndrome: \u201catypical\u201d or melancholic features. Clin Endocrinol (Oxf) 43(4):433\u2013442","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"511_CR10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2001.01261.x","volume":"54","author":"GH Chee","year":"2001","unstructured":"Chee GH, Mathias DB, James RA, Kendall-Taylor P (2001) Transsphenoidal pituitary surgery in Cushing\u2019s disease: can we predict outcome? Clin Endocrinol (Oxf) 54(5):617\u2013626","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"511_CR11","first-page":"5695","volume":"86","author":"J Estrada","year":"2001","unstructured":"Estrada J, Garcia-Uria J, Lamas C, Alfaro J, Lucas T, Diez S, Salto L, Barcelo B (2001) The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing\u2019s disease. J Clin Endocrinol Metab 86(12):5695\u20135699","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"511_CR12","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1210\/jc.2003-030751","volume":"88","author":"AM Pereira","year":"2003","unstructured":"Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F, Romijn JA (2003) Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing\u2019s disease. J Clin Endocrinol Metab 88(12):5858\u20135864","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"511_CR13","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1210\/jc.2008-1171","volume":"93","author":"CA Carrasco","year":"2008","unstructured":"Carrasco CA, Coste J, Guignat L, Groussin L, Duque MA, Gaillard S, Bertagna X, Betherat J (2008) Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing\u2019s disease. J Clin Endocrinol Metab 93(12):4728\u20134734","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"511_CR14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/eje.0.1510727","volume":"151","author":"R Valero","year":"2004","unstructured":"Valero R, Vallette-Kasic S, Conte-Devolx B, Jaquet P, Brue T (2004) The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing\u2019s disease. Eur J Endocrinol 151(6):727\u2013733","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"511_CR15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1373\/clinchem.2010.143263","volume":"56","author":"V Salem","year":"2010","unstructured":"Salem V, Dhillo WS, Meeran K, Donaldson M, Martin NM (2010) Dexamethasone-suppressed corticotrophin-releasing hormone-stimulation test does not reliably diagnose or predict recurrence of Cushing disease. Clin Chem 56(6):1031\u20131034","journal-title":"Clin Chem"},{"issue":"6","key":"511_CR16","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jcem-64-6-1150","volume":"64","author":"U Schrell","year":"1987","unstructured":"Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Muller OA (1987) Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing\u2019s disease. J Clin Endocrinol Metab 64(6):1150\u20131159","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"511_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00006123-200207000-00008","volume":"51","author":"I Shimon","year":"2002","unstructured":"Shimon I, Ram Z, Cohen ZR, Hadani M (2002) Transsphenoidal surgery for Cushing\u2019s disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 51(1):57\u201361 discussion 61-2","journal-title":"Neurosurgery"},{"issue":"12","key":"511_CR18","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","volume":"89","author":"GD Hammer","year":"2004","unstructured":"Hammer GD, Tyrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB (2004) Transsphenoidal microsurgery for Cushing\u2019s disease: initial outcome and long-term results. J Clin Endocrinol Metab 89(12):6348\u20136357","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"511_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","volume":"63","author":"AB Atkinson","year":"2005","unstructured":"Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B (2005) Long-term remission rates after pituitary surgery for Cushing\u2019s disease: the need for long-term surveillance. Clin Endocrinol (Oxf) 63(5):549\u2013559","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"511_CR20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3171\/jns.2003.98.5.0967","volume":"98","author":"JC Chen","year":"2003","unstructured":"Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH (2003) Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98(5):967\u2013973","journal-title":"J Neurosurg"},{"issue":"1","key":"511_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/jc.2005-1204","volume":"91","author":"F Esposito","year":"2006","unstructured":"Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, Swerdloff RS, Kelly DF (2006) Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing\u2019s disease. J Clin Endocrinol Metab 91(1):7\u201313","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"511_CR22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","volume":"56","author":"DA Rees","year":"2002","unstructured":"Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF (2002) Long-term follow-up results of transsphenoidal surgery for Cushing\u2019s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56(4):541\u2013551","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"511_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.0300-0664.2001.01444.x","volume":"56","author":"LB Yap","year":"2002","unstructured":"Yap LB, Turner HE, Adams CB, Wass JA (2002) Undetectable postoperative cortisol does not always predict long-term remission in Cushing\u2019s disease: a single centre audit. Clin Endocrinol (Oxf) 56(1):25\u201331","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"511_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1996.614436.x","volume":"44","author":"DR McCance","year":"1996","unstructured":"McCance DR, Besser M, Atkinson AB (1996) Assessment of cure after transsphenoidal surgery for Cushing\u2019s disease. Clin Endocrinol (Oxf) 44(1):1\u20136","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"511_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1993.tb00975.x","volume":"38","author":"PJ Trainer","year":"1993","unstructured":"Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM (1993) Transsphenoidal resection in Cushing\u2019s disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 38(1):73\u201378","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"511_CR26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jcem-69-6-1122","volume":"69","author":"GF Pieters","year":"1989","unstructured":"Pieters GF, Hermus AR, Meijer E, Smals AG, Kloppenborg PW (1989) Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing\u2019s disease. J Clin Endocrinol Metab 69(6):1122\u20131126","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"511_CR27","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/jc.2004-2436","volume":"90","author":"M Locatelli","year":"2005","unstructured":"Locatelli M, Vance ML, Laws ER (2005) Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing\u2019s disease. J Clin Endocrinol Metab 90(9):5478\u20135482","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"511_CR28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","volume":"93","author":"CG Patil","year":"2008","unstructured":"Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER (2008) Late recurrences of Cushing\u2019s disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 93(2):358\u2013362","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"511_CR29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","volume":"168","author":"KI Alexandraki","year":"2013","unstructured":"Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL, Drake WM, Monson JP, Besser GM, Grossman AB (2013) Long-term remission and recurrence rates in Cushing\u2019s disease: predictive factors in a single-centre study. Eur J Endocrinol 168(4):639\u2013648","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"511_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/JNS\/2008\/108\/01\/0009","volume":"108","author":"BM Hofmann","year":"2008","unstructured":"Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Muller OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35\u00a0years. J Neurosurg 108(1):9\u201318","journal-title":"J Neurosurg"},{"issue":"2","key":"511_CR31","first-page":"291","volume":"76","author":"GC Toms","year":"1993","unstructured":"Toms GC, McCarthy MI, Nieven MJ, Orteu CH, King TT, Monson JP (1993) Predicting relapse after transsphenoidal surgery for Cushing\u2019s disease. J Clin Endocrinol Metab 76(2):291\u2013294","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"511_CR32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jc.2009-1672","volume":"95","author":"E Valassi","year":"2010","unstructured":"Valassi E, Biller BM, Swearingen B, Pecori Giraldi F, Losa M, Mortini P, Hayden D, Cavagnini F, Klibanski A (2010) Delayed remission after transsphenoidal surgery in patients with Cushing\u2019s disease. J Clin Endocrinol Metab 95(2):601\u2013610","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"511_CR33","first-page":"3114","volume":"80","author":"D Bochicchio","year":"1995","unstructured":"Bochicchio D, Losa M, Buchfelder M (1995) Factors influencing the immediate and late outcome of Cushing\u2019s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing\u2019s Disease Survey Group. J Clin Endocrinol Metab 80(11):3114\u20133120","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"511_CR34","first-page":"647","volume":"19","author":"J Newell-Price","year":"1998","unstructured":"Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states. Endocr Rev 19(5):647\u2013672","journal-title":"Endocr Rev"},{"issue":"6","key":"511_CR35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-07-0424","volume":"157","author":"S Kidambi","year":"2007","unstructured":"Kidambi S, Raff H, Findling JW (2007) Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing\u2019s syndrome. Eur J Endocrinol 157(6):725\u2013731","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"511_CR36","first-page":"2681","volume":"83","author":"H Raff","year":"1998","unstructured":"Raff H, Raff JL, Findling JW (1998) Late-night salivary cortisol as a screening test for Cushing\u2019s syndrome. J Clin Endocrinol Metab 83(8):2681\u20132686","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"511_CR37","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1210\/jc.2003-030312","volume":"88","author":"P Putignano","year":"2003","unstructured":"Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F (2003) Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing\u2019s syndrome. J Clin Endocrinol Metab 88(9):4153\u20134157","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"511_CR38","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1227\/01.NEU.0000215945.26764.92","volume":"58","author":"BM Hofmann","year":"2006","unstructured":"Hofmann BM, Hlavac M, Kreutzer J, Grabenbauer G, Fahlbusch R (2006) Surgical treatment of recurrent Cushing\u2019s disease. Neurosurgery 58(6):1108\u20131118 discussion 1108\u20131118","journal-title":"Neurosurgery"},{"issue":"6","key":"511_CR39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3171\/jns.2002.97.6.1343","volume":"97","author":"RD Dickerman","year":"2002","unstructured":"Dickerman RD, Oldfield EH (2002) Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97(6):1343\u20131349","journal-title":"J Neurosurg"},{"issue":"2","key":"511_CR40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1227\/00006123-198708000-00015","volume":"21","author":"T Nakane","year":"1987","unstructured":"Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, Ichihara K, Kageyama N (1987) Long term results of transsphenoidal adenomectomy in patients with Cushing\u2019s disease. Neurosurgery 21(2):218\u2013222","journal-title":"Neurosurgery"},{"issue":"6","key":"511_CR41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3171\/jns.2005.102.6.1004","volume":"102","author":"RJ Benveniste","year":"2005","unstructured":"Benveniste RJ et al (2005) Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg 102(6):1004\u20131012","journal-title":"J Neurosurg"},{"key":"511_CR42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000091580","volume":"34","author":"BM Hofmann","year":"2006","unstructured":"Hofmann BM, Fahlbusch R (2006) Treatment of Cushing\u2019s disease: a retrospective clinical study of the latest 100 cases. Front Horm Res 34:158\u2013184","journal-title":"Front Horm Res"},{"key":"511_CR43","first-page":"31","volume":"65","author":"UJ Knappe","year":"1996","unstructured":"Knappe UJ, L\u00fcdecke DK (1996) Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing\u2019s disease. Acta Neurochir Suppl 65:31\u201334","journal-title":"Acta Neurochir Suppl"},{"issue":"4","key":"511_CR44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3171\/jns.1989.71.4.0520","volume":"71","author":"RB Friedman","year":"1989","unstructured":"Friedman RB, Oldfield RB, Nieman LK, Chrousos GP, Doppman JL, Cutler GB, Loriaux DL (1989) Repeat transsphenoidal surgery for Cushing\u2019s disease. J Neurosurg 71(4):520\u2013527","journal-title":"J Neurosurg"},{"issue":"3","key":"511_CR45","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1227\/00006123-199609000-00010","volume":"39","author":"UJ Knappe","year":"1996","unstructured":"Knappe UJ, L\u00fcdecke DK (1996) Transnasal microsurgery in children and adolescents with Cushing\u2019s disease. Neurosurgery 39(3):484\u2013492 discussion 492\u2013493","journal-title":"Neurosurgery"},{"issue":"2","key":"511_CR46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1227\/01.NEU.0000313117.35824.9F","volume":"63","author":"CG Patil","year":"2008","unstructured":"Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER (2008) Outcomes after repeat transsphenoidal surgery for recurrent Cushing\u2019s disease. Neurosurgery 63(2):266\u2013270 discussion 270\u2013271","journal-title":"Neurosurgery"},{"issue":"3","key":"511_CR47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","volume":"336","author":"J Estrada","year":"1997","unstructured":"Estrada J, Boronat M, Mielgo M, Magall\u00f3n R, Millan I, D\u00edez S, Lucas T, Barcel\u00f3 B (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease. N Engl J Med 336(3):172\u2013177","journal-title":"N Engl J Med"},{"issue":"1","key":"511_CR48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S0317167100011227","volume":"38","author":"N McLaughlin","year":"2011","unstructured":"McLaughlin N, Kassam AB, Prevedello DM, Kelly DF (2011) Management of Cushing\u2019s disease after failed surgery\u2013a review. Can J Neurol Sci 38(1):12\u201321","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"511_CR49","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3171\/jns.2000.93.5.0738","volume":"93","author":"JM Sheehan","year":"2000","unstructured":"Sheehan JM, Vance ML, Sheehan JP, Ellegala DB, Laws ER (2000) Radiosurgery for Cushing\u2019s disease after failed transsphenoidal surgery. J Neurosurg 93(5):738\u2013742","journal-title":"J Neurosurg"},{"issue":"6","key":"511_CR50","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3171\/jns.2007.106.6.980","volume":"106","author":"J Jagannathan","year":"2007","unstructured":"Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML (2007) Gamma Knife surgery for Cushing\u2019s disease. J Neurosurg 106(6):980\u2013987","journal-title":"J Neurosurg"},{"issue":"1","key":"511_CR51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/eje.1.02323","volume":"156","author":"F Castinetti","year":"2007","unstructured":"Castinetti F, Nagai M, Dufour H, Kuhn JM, Morange I, Jaquet P, Conte-Devolx B, Regis J, Brue T (2007) Gamma knife radiosurgery is a successful adjunctive treatment in Cushing\u2019s disease. Eur J Endocrinol 156(1):91\u201398","journal-title":"Eur J Endocrinol"},{"key":"511_CR52","first-page":"141","volume":"55","author":"MK Aghi","year":"2008","unstructured":"Aghi MK, Petit J, Chapman P, Loeffler J, Klibanski A, Biller BK, Swearingen B (2008) Management of recurrent and refractory Cushing\u2019s disease with reoperation and\/or proton beam radiosurgery. Clin Neurosurg 55:141\u2013144","journal-title":"Clin Neurosurg"},{"issue":"2","key":"511_CR53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jc.2007-1220","volume":"93","author":"JH Petit","year":"2008","unstructured":"Petit JH, Biller BK, Yock TI, Swearingen B, Coen JJ, Chapman P, Ancukiewicz M, Bussiere M, Klibanski A, Loeffler JS (2008) Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab 93(2):393\u2013399","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"511_CR54","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/foc.2007.23.3.7","volume":"23","author":"DF Kelly","year":"2007","unstructured":"Kelly DF (2007) Transsphenoidal surgery for Cushing\u2019s disease: a review of success rates, remission predictors, management of failed surgery, and Nelson\u2019s Syndrome. Neurosurg Focus 23(3):E5","journal-title":"Neurosurg Focus"},{"issue":"4","key":"511_CR55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.03082.x","volume":"68","author":"JT Chow","year":"2008","unstructured":"Chow JT, Thompson GB, Grant CS, Farley DR, Richards ML, Young WF (2008) Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing\u2019s syndrome: a review of the Mayo Clinic experience. Clin Endocrinol (Oxf) 68(4):513\u2013519","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"511_CR56","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.sla.0000251578.03883.2f","volume":"245","author":"SK Thompson","year":"2007","unstructured":"Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing\u2019s disease: a 10-year experience. Ann Surg 245(5):790\u2013794","journal-title":"Ann Surg"},{"issue":"1","key":"511_CR57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","volume":"92","author":"G Assi\u00e9","year":"2007","unstructured":"Assi\u00e9 G, Bahurel H, Coste J, Silvera S, Kujas M, Dugu\u00e9 MA, Karray F, Dousset B, Bertherat J, Legmann P, Bertagna X (2007) Corticotroph tumor progression after adrenalectomy in Cushing\u2019s Disease: a reappraisal of Nelson\u2019s Syndrome. J Clin Endocrinol Metab 92(1):172\u2013179","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"511_CR58","first-page":"1127","volume":"98","author":"FC Brunicardi","year":"1985","unstructured":"Brunicardi FC, Rosman PM, Lesser KL, Andersen DK (1985) Current status of adrenalectomy for Cushing\u2019s disease. Surgery 98(6):1127\u20131134","journal-title":"Surgery"},{"issue":"7","key":"511_CR59","first-page":"2647","volume":"81","author":"N Sonino","year":"1996","unstructured":"Sonino N, Zielezney M, Fava GA, Fallo F, Boscaro M (1996) Risk factors and long-term outcome in pituitary-dependent Cushing\u2019s disease. J Clin Endocrinol Metab 81(7):2647\u20132652","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"511_CR60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","volume":"14","author":"JW Miller","year":"1993","unstructured":"Miller JW, Crapo L (1993) The medical treatment of Cushing\u2019s syndrome. Endocr Rev 14(4):443\u2013458","journal-title":"Endocr Rev"},{"issue":"1","key":"511_CR61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-07-0514","volume":"158","author":"F Castinetti","year":"2008","unstructured":"Castinetti F, Morange I, Jaquet P, Conte-Devolx B, Brue T (2008) Ketoconazole revisited: a preoperative or postoperative treatment in Cushing\u2019s disease. Eur J Endocrinol 158(1):91\u201399","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"511_CR62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0889-8529(05)70064-5","volume":"28","author":"N Sonino","year":"1999","unstructured":"Sonino N, Boscaro M (1999) Medical therapy for Cushing\u2019s disease. Endocrinol Metab Clin North Am 28(1):211\u2013222","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"511_CR63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00024677-200504020-00003","volume":"4","author":"N Sonino","year":"2005","unstructured":"Sonino N, Boscaro M, Fallo F (2005) Pharmacologic management of Cushing syndrome: new targets for therapy. Treat Endocrinol 4(2):87\u201394","journal-title":"Treat Endocrinol"},{"issue":"3","key":"511_CR64","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11102-012-0397-5","volume":"15","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Petersenn S (2012) Medical management of Cushing\u2019s disease: what is the future? Pituitary 15(3):330\u2013341","journal-title":"Pituitary"},{"issue":"2","key":"511_CR65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2265.1988.tb03658.x","volume":"28","author":"AC Hale","year":"1988","unstructured":"Hale AC, Coates PJ, Doniach I, Howlett TA, Grossman A, Rees LH, Besser GM (1988) A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing\u2019s disease. Clin Endocrinol (Oxf) 28(2):215\u2013223","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"511_CR66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2265.1986.tb03621.x","volume":"25","author":"HP Koppeschaar","year":"1986","unstructured":"Koppeschaar HP, Croughs RJ, Thijssen JH, Schwarz F (1986) Response to neurotransmitter modulating drugs in patients with Cushing\u2019s disease. Clin Endocrinol (Oxf) 25(6):661\u2013667","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"511_CR67","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/jc.2003-030837","volume":"89","author":"R Pivonello","year":"2004","unstructured":"Pivonello R, Ferone D, de Herder WW, Kros JM, De Caro MLDB, Arvigo M, Annunziato L, Lombardi G, Colao A, Hofland LJ, Lamberts SWJ (2004) Dopamine receptor expression and function in corticotroph pituitary tumors. J Clin Endocrinol Metab 89(5):2452\u20132462","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"511_CR68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","volume":"94","author":"R Pivonello","year":"2009","unstructured":"Pivonello R, De Martino MC, Cappabianca P, De Leo M, Faggiano A, Lombardi G, Hofland LJ, Lamberts SWJ, Colao A (2009) The medical treatment of Cushing\u2019s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab 94(1):223\u2013230","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"511_CR69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","volume":"163","author":"A Godbout","year":"2010","unstructured":"Godbout A, Manavela M, Danilowicz K, Beauregard H, Bruno OD, Lacroix A (2010) Cabergoline monotherapy in the long-term treatment of Cushing\u2019s disease. Eur J Endocrinol 163(5):709\u2013716","journal-title":"Eur J Endocrinol"},{"key":"511_CR70","doi-asserted-by":"crossref","unstructured":"Colao A, Petersenn S, Newell-Price J (2011) Pasireotide (SOM230) demonstrates efficacy in patients with Cushing disease: results from a large, randomized-dose, double-blind, phase III study. in ENDO 2011. Boston","DOI":"10.1210\/endo-meetings.2011.PART1.OR10.OR09-6"},{"issue":"10","key":"511_CR71","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","volume":"366","author":"A Colao","year":"2012","unstructured":"Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM, Pasireotide B2305 Study Group (2012) A 12-month phase 3 study of pasireotide in Cushing\u2019s disease. N Engl J Med 366(10):914\u2013924","journal-title":"N Engl J Med"},{"issue":"6","key":"511_CR72","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C, SEISMIC Study Investigators (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97(6):2039\u20132049","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"511_CR73","first-page":"63","volume":"83","author":"LS Blevins","year":"1998","unstructured":"Blevins LS, Christy JH, Khajavi M, Tindall GT (1998) Outcomes of therapy for Cushing\u2019s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 83(1):63\u201367","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"511_CR74","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s007010170077","volume":"143","author":"L Barbetta","year":"2001","unstructured":"Barbetta L, Dall\u2019Asta C, Tomei G, Locatelli M, Giovanelli M, Ambrosi B (2001) Assessment of cure and recurrence after pituitary surgery for Cushing\u2019s disease. Acta Neurochir (Wein) 143(5):477\u2013481 discussion 481-482","journal-title":"Acta Neurochir (Wein)"},{"issue":"3","key":"511_CR75","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2003-031170","volume":"89","author":"GA Rollin","year":"2004","unstructured":"Rollin GA, Ferreira NP, Junges M, Gross JL, Czepielewski MA (2004) Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing\u2019s disease. J Clin Endocrinol Metab 89(3):1131\u20131139","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"511_CR76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.1983.59.2.0195","volume":"59","author":"JE Boggan","year":"1983","unstructured":"Boggan JE, Tyrrell JB, Wilson CB (1983) Transsphenoidal microsurgical management of Cushing\u2019s disease. Report of 100 cases. J Neurosurg 59(2):195\u2013200","journal-title":"J Neurosurg"},{"issue":"2","key":"511_CR77","first-page":"440","volume":"84","author":"C Invitti","year":"1999","unstructured":"Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84(2):440\u2013448","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"511_CR78","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2008-2234","volume":"94","author":"F Castinetti","year":"2009","unstructured":"Castinetti F, Martinie M, Morange I, Dufour H, Sturm N, Passagia JG, Conte-Devolx B, Chabre O, Brue T (2009) A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing\u2019s disease. J Clin Endocrinol Metab 94(6):1897\u20131903","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"511_CR79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-012-0394-8","volume":"15","author":"E Valassi","year":"2012","unstructured":"Valassi E, Crespo I, Santos A, Webb SM (2012) Clinical consequences of Cushing\u2019s syndrome. Pituitary 15(3):319\u2013329","journal-title":"Pituitary"},{"key":"511_CR80","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1359\/jbmr.061010","volume":"22","author":"GM Leong","year":"2007","unstructured":"Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, Nieman LK (2007) Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into young adulthood. J Bone Miner Res 22:110\u2013118","journal-title":"J Bone Miner Res"},{"issue":"9","key":"511_CR81","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","volume":"94","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E, Fern\u00e1ndez-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J, Webb SM (2009) Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing\u2019s syndrome. J Clin Endocrinol Metab 94(9):3365\u20133371","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"511_CR82","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2265.2003.01987.x","volume":"60","author":"M Krsek","year":"2004","unstructured":"Krsek M, Silha JV, Jezkov\u00e1 J, H\u00e1na V, Marek J, Weiss V, Step\u00e1n JJ, Murphy LJ (2004) Adipokine levels in Cushing\u2019s syndrome; elevated resistin levels in female patients with Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 60(3):350\u2013357","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"511_CR83","first-page":"2664","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab 84(8):2664\u20132672","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"511_CR84","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jc.2009-2032","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJSA, Wassenaar MJ, Middelkoop HAM, Pereira AM, Romijn JA (2010) Subtle cognitive impairments in patients with long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95(6):2699\u20132714","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"511_CR85","first-page":"21","volume":"13","author":"JN Hook","year":"2007","unstructured":"Hook JN, Giordani B, Schteingart DE, Guire K, Giles J, Ryan K, Gebarski SS, Langenecker SA, Starkman MN (2007) Patterns of cognitive change over time and relationship to age following successful treatment of Cushing\u2019s disease. J Int Neuropsychol Soc 13(1):21\u201329","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"511_CR86","first-page":"912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82(3):912\u2013919","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"511_CR87","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, Middelkoop HAM, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95(10):E129\u2013E141","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"511_CR88","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","volume":"90","author":"MO Aken van","year":"2005","unstructured":"van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JWA, Roelfsema F, Lamberts SWJ, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease. J Clin Endocrinol Metab 90(6):3279\u20133286","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"511_CR89","first-page":"117","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm J, Juul S, J\u00f8rgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, J\u00f8rgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of cushing\u2019s syndrome: a population-based study. J Clin Endocrinol Metab 86(1):117\u2013123","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"511_CR90","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","volume":"91","author":"JR Lindsay","year":"2006","unstructured":"Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing\u2019s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91(2):447\u2013453","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"511_CR91","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, van Aken MO, Pivonello R, Stalla G, Lamberts SWJ et al (2008) Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire. Eur J Endocrinol 158(5):623\u2013630","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"511_CR92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02067","volume":"154","author":"C Kristo","year":"2006","unstructured":"Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing\u2019s syndrome: a prospective, long-term study. Eur J Endocrinol 154(1):109\u2013118","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"511_CR93","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1359\/jbmr.090505","volume":"24","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E, Fern\u00e1ndez-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, W\u00e4gner AM, Rodriguez-Espinosa J, Farrerons J, Webb SM (2009) Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing\u2019s syndrome. J Bone Miner Res 24(11):1841\u20131846","journal-title":"J Bone Miner Res"},{"issue":"3","key":"511_CR94","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","volume":"98","author":"JK Lambert","year":"2013","unstructured":"Lambert JK, Goldberg L, Fayngold S, Kostadinov J, Post KD, Geer EB (2013) Predictors of mortality and long-term outcomes in treated Cushing\u2019s disease: a study of 346 patients. J Clin Endocrinol Metab 98(3):1022\u20131030","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0511-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-013-0511-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0511-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T09:51:39Z","timestamp":1563789099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-013-0511-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s11102-013-0511-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}